Predictors of Abstinence and Changes in Psychiatric Symptoms in a Pooled Sample of Smokers with Schizophrenia receiving Combination Pharmacotherapy and Behavioral Therapy for Smoking Cessation

Similar Items

• Effects of Acute Abstinence, Reinstatement, and Mecamylamine on Biochemical and Behavioral Measures of Cigarette Smoking in Schizophrenia
  od: Weinberger, Andrea H., i dr.
  Izdano: (2007)
• Pharmacotherapy for Smoking Cessation in Schizophrenia: A systematic review
  od: Kozak, Karolina, i dr.
  Izdano: (2020)
• Prefrontal Cognitive Dysfunction is Associated with Tobacco Dependence Treatment Failure in Smokers with Schizophrenia
  od: Moss, Taryn G., i dr.
  Izdano: (2009)
• A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
  od: George, Tony P., i dr.
  Izdano: (2007)
• Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation
  od: Weinberger, Andrea H., i dr.
  Izdano: (2010)